Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc

(2013) Kenta Masui et al.   Cell Metabolism

A Comparison between Manual and Automated Evaluations of Tissue Microarray Patterns of Protein Expression

(2013) Arthur W. Alvarenga et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Development of PI3K inhibitors: lessons learned from early clinical trials

(2013) Jordi Rodon et al.   Nature Reviews Clinical Oncology

Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target

(2013) Marianne Hütt-Cabezas et al.   NEURO-ONCOLOGY

Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas

(2012) Penelope Korkolopoulou et al.   HISTOPATHOLOGY

PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome

(2012) S. Mueller et al.   NEURO-ONCOLOGY

Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice

(2012) Tariq Bashir et al.   PLoS One

Rapamycin passes the torch: a new generation of mTOR inhibitors

(2011) Don Benjamin et al.   NATURE REVIEWS DRUG DISCOVERY

PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma

(2010) Erika F. Rodriguez et al.   ACTA NEUROPATHOLOGICA

Increased expression of Akt2 and activity of PI3K and cell proliferation with the ascending of tumor grade of human gliomas

(2010) Guangxiu Wang et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas

(2010) Xue-yuan Li et al.   JOURNAL OF NEURO-ONCOLOGY

A Nuclear Complex of Rictor and Insulin Receptor Substrate-2 Is Associated with Albuminuria in Diabetic Mice

(2010) Baljit K. Singh et al.   Metabolic Syndrome and Related Disorders

Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells

(2010) Gowry Das et al.   MOLECULAR CARCINOGENESIS

mTOR: from growth signal integration to cancer, diabetes and ageing

(2010) Roberto Zoncu et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

mTOR signaling in glioblastoma: lessons learned from bench to bedside

(2010) D. Akhavan et al.   NEURO-ONCOLOGY

Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma

(2009) Tomoo Matsutani et al.   ACTA NEUROCHIRURGICA

In pursuit of prognostic factors in children with pilocytic astrocytomas

(2009) Aline Paixão Becker et al.   CHILDS NERVOUS SYSTEM

Targeting the PI3K signaling pathway in cancer

(2009) Kwok-Kin Wong et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival

(2009) Sean M. McBride et al.   JOURNAL OF NEURO-ONCOLOGY

Molecular mechanisms of mTOR-mediated translational control

(2009) Xiaoju Max Ma et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas

(2008) H. K. Thorarinsdottir et al.   CLINICAL CANCER RESEARCH

Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1

(2008) M. Rosner et al.   HUMAN MOLECULAR GENETICS

Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

(2008) Tim F Cloughesy et al.   PLOS MEDICINE